AKT1 and breast carcinoma: In summary, we immunolocalized ARHGAP15 and Rac GAP in human breast carcinoma tissues, and ARHGAP15 immunoreactivity was significantly correlated with AR LI, decreased risk of recurrence, and better prognosis for the patients.